Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 27.10
+0.71 (2.69%)
Aug 4, 2026, 3:00 PM CST
SHA:688399 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,276 | 5,745 | 3,727 | 3,198 | 5,142 | 8,060 | |
Market Cap Growth | -33.46% | 54.17% | 16.52% | -37.80% | -36.21% | -28.51% |
Enterprise Value | 2,107 | 4,547 | 1,979 | 988 | 3,046 | 6,689 |
Last Close Price | 26.39 | 46.28 | 28.44 | 23.61 | 37.95 | 55.29 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 2.81 | 6.76 |
PS Ratio | 10.05 | 16.95 | 10.66 | 7.93 | 0.93 | 2.84 |
PB Ratio | 1.11 | 1.96 | 1.15 | 0.94 | 1.36 | 3.18 |
P/TBV Ratio | 1.12 | 1.98 | 1.16 | 0.95 | 1.37 | 3.21 |
P/FCF Ratio | - | - | 44.86 | - | 3.19 | 11.82 |
P/OCF Ratio | 139.84 | 189.35 | 25.54 | - | 2.62 | 8.18 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.46 | 13.41 | 5.66 | 2.45 | 0.55 | 2.36 |
EV/EBITDA Ratio | - | - | - | - | 1.35 | 4.98 |
EV/EBIT Ratio | - | - | - | - | 1.40 | 5.10 |
EV/FCF Ratio | - | - | 23.82 | - | 1.89 | 9.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.18 | 0.13 | 0.07 | 0.05 | 0.03 | 0.07 |
Debt / EBITDA Ratio | - | - | - | - | 0.05 | 0.12 |
Debt / FCF Ratio | - | - | 2.90 | - | 0.06 | 0.24 |
Net Debt / Equity Ratio | -0.40 | -0.41 | -0.53 | -0.67 | -0.72 | -0.69 |
Net Debt / EBITDA Ratio | 69.41 | 43.38 | 97.12 | 7.26 | -1.20 | -1.30 |
Net Debt / FCF Ratio | 16.65 | 35.27 | -20.93 | 10.20 | -1.67 | -2.56 |
Asset Turnover | 0.09 | 0.09 | 0.09 | 0.09 | 1.32 | 0.98 |
Inventory Turnover | 2.83 | 2.51 | 1.84 | 1.54 | 9.78 | 4.26 |
Quick Ratio | 3.22 | 3.49 | 5.59 | 7.14 | 3.69 | 2.65 |
Current Ratio | 3.33 | 3.63 | 5.82 | 7.45 | 3.98 | 2.97 |
Return on Equity (ROE) | -1.05% | -1.33% | -0.06% | -10.41% | 57.89% | 56.81% |
Return on Assets (ROA) | -1.08% | -1.31% | -1.13% | -5.46% | 32.37% | 28.36% |
Return on Invested Capital (ROIC) | -3.72% | -4.73% | 2.51% | -35.11% | 199.17% | 210.54% |
Return on Capital Employed (ROCE) | -2.10% | -2.50% | -2.00% | -10.80% | 54.90% | 49.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.00% | -0.71% | -0.05% | -11.69% | 35.55% | 14.80% |
FCF Yield | -2.14% | -0.59% | 2.23% | -7.02% | 31.39% | 8.46% |
Dividend Yield | 8.48% | 4.96% | - | - | - | 8.26% |
Payout Ratio | - | - | - | - | 32.31% | 27.27% |
Buyback Yield / Dilution | 16.18% | 16.33% | -15.53% | 0.06% | -0.03% | 0.02% |
Total Shareholder Return | 24.95% | 21.29% | -15.53% | 0.06% | -0.03% | 8.28% |